Timothy Mooney, DPM
Foot & Ankle Surgery · Sparks, NVNPI 1891716478
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.0%), education and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 42.0% of the total. Reporting peaked in 2022 at $1,307 and has fallen 97.1% since, to $37 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NV, where the typical reported total is $3,921.
Across 26 payments — averaging $155.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Sequoia Surgical, Inc.$1K
- Paragon 28, Inc.$1K
- Biotissue Holdings Inc.$33
- Nevro Corp.$32
- Fusion Orthopedics USA, LLC$13
What the payments were for
- Travel & lodging$1,81645%
- Food & beverage$1,01625%
- Education$1,20030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 15 | $1,695 |
| Sequoia Surgical, Inc. | 2 | $1,212 |
| Paragon 28, Inc. | 5 | $1,047 |
| Biotissue Holdings Inc. | 2 | $33 |
| Nevro Corp. | 1 | $32 |
| Fusion Orthopedics USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,230
How this compares
$4,032 in reported general payments places this provider in the 50th percentile of 84 foot & ankle surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 23 | $400 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $336 |
| Meloxicam | 35 | $148 |
| Methylprednisolone | 20 | $140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $109 |
| Terbinafine Hcl | 19 | $67 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Sparks
- Troy WatsonLas Vegas$1.2M
- Roman SibelHenderson$309K
- Gregory LundeenReno$301K
- Ira WeinerLas Vegas$135K
- Abdolreza RaissiLas Vegas$110K
- Holman ChanHenderson$75K
- Michael AraminiReno$60K
- Jeremy TiltonHenderson$51K
- Anthony BorgiaLas Vegas$47K
- Scott WhitlowReno$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.